Hydrogen Peroxide Solution
FDA Recall NDC 59779-871
FDA Enforcement Report: View Recall Date, Reasons, and Safety Status
Active & Historical Enforcement Reports
The FDA has identified 1 recorded enforcement report(s) associated with Hydrogen Peroxide (NDC 59779-871). A significant event, classified as Class II, was initiated on Jun 24, 2022 by Cvs Pharmacy, Inc.. The reported reason for this action was: "Labeling: Label Mix-Up-The primary label on the front of the bottles have Hydrogen Peroxide affixed to the front and back of the containers. However, the product inside the bottle is 70% Isopropyl Alcohol."
This specific recall has a current status of TERMINATED, indicating that the FDA considers the recall process finished or the product successfully recovered.
This specific recall has a current status of TERMINATED, indicating that the FDA considers the recall process finished or the product successfully recovered.
Reported Recall Events
Class II Terminated
Labeling: Label Mix-Up-The primary label on the front of the bottles have Hydrogen Peroxide affixed to the front and back of the containers. However, the product inside the bottle is 70% Isopropyl Alcohol.
Jun 24, 2022
Jul 20, 2022
36,840 bottles
Recall Profile & Regulatory Data
Event ID
90509
Classification
Class II
Enforcement Status
Terminated
Recalling Firm
Vi-Jon, LLC
Voluntary / Mandated
Voluntary: Firm initiated
Distribution Pattern
USA Nationwide
Termination Date
Jun 17, 2024
Product Description
Hydrogen Peroxide Topical Solution, USP, 32 fl. oz. (1 QT) 946 mL, Distributed by: CVS Pharmacy, Inc. One CVS Drive Woonsocket, RI 02895, NDC 59779-871-45, UPC 0-50428-40950-3
Batch or Lot Expiration Information
Lot# Lot: 0562272, Exp 02/2025
Affected Packages Involved in this Recall
59779-871-43Product
59779-871-45Product
59779-871-50Product
59779-871-99Product
About FDA Recall Enforcement Reports
FDA recall data documents classified recall actions associated with a product. Most recalls are limited to specific lots, batches, or package configurations rather than every unit of a drug.
If a recall is listed for an NDC, review the affected lot information and package details carefully. Patients and healthcare professionals should confirm whether a specific product in hand matches the lot or package information before assuming it is affected.
